MAPK8 Protein (JNK1)
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MAPK8 Protein (JNK1)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>MAPK8</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P45985</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>46 kDa</td>
</tr>
<tr>
<td class="label">Length</td>
<td>427 amino acids</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Nucleus</td>
</tr>
<tr>
<td class="label">Family</td>
<td>MAPK family, JNK subfamily</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>JNK1, JNK1A, SAPK1</td>
</tr>
<tr>
<td class="label">Kinase Domain</td>
<td>residues 47-310</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">JNK inhibitors</td>
<td>SP600125</td>
</tr>
<tr>
<td class="label">Selective inhibitors</td>
<td>JNK-IN-8</td>
</tr>
<tr>
<td class="label">Peptide inhibitors</td>
<td>TAT-JIP</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Dominant-negative JNK</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">408 edges</a></td>
</tr>
</table>
Mapk8 Protein (Jnk1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
MAPK8 (Mitogen-Activated Protein Kinase 8), also known as JNK1 (c-Jun N-terminal Kinase 1), is a serine/threonine protein kinase that plays critical roles in stress response, inflammation, cell proliferation, and [apoptosis](/entities/apoptosis). JNK1 is one of three JNK isoforms (JNK1, JNK2, JNK3) and is widely expressed in most tissues, including the brain. It is encoded by the MAPK8 gene on chromosome 10q11.22.
MAPK8 has multiple isoforms due to alternative splicing:
- JNK1α1: Full-length isoform (427 aa)
- JNK1α2: Alternative splice variant
- JNK1β1, β2: Additional variants
Structure
The JNK1 protein contains:
Kinase domain (KD): Catalytic core with ATP-binding site (residues 47-310)
Docking domain (D-domain): For substrate and upstream kinase binding
Nuclear localization signals (NLS): For nuclear import
Transactivation domain (TAD): For interacting with transcription factorsJNK1 is activated by dual phosphorylation on Thr183 and Tyr185 by upstream MAP2Ks (MKK4 and MKK7).
Normal Function
Stress-Activated Signaling
JNK1 responds to various cellular stresses:
- Oxidative stress: [Reactive oxygen species](/entities/reactive-oxygen-species) (ROS), UV radiation
- Cytokine signaling: TNF-α, IL-1β, IL-6
- Growth factor deprivation
- DNA damage: UV, gamma radiation
- Mechanical stress
Signal Transduction Cascade
The JNK pathway follows a three-tier kinase cascade:
Stress/Growth Factors → MAP3Ks (MEKK1-4, MLK2/3, TAK1) → MAP2Ks (MKK4, MKK7) → MAPK8/JNK1 → Transcription factors
Key Targets-Jun**: AP-1 transcription factor component (Ser63/73 phosphorylation)
- ATF2: Activating transcription factor 2 (Thr69/71 phosphorylation)
- ELK1: ETS domain-containing protein
- p53: Tumor suppressor
- Bim, Bad: Pro-apoptotic Bcl-2 family proteins
- NFAT: Nuclear factor of activated T cells
Expression Pattern
MAPK8/JNK1 is expressed in:
- Brain: [Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, cerebellum, hypothalamus
- Immune cells: T cells, B cells, NK cells, macrophages
- Peripheral tissues: Heart, liver, lung, kidney, spleen
- Endocrine system: Pancreas, thyroid
In [neurons](/entities/neurons), JNK1 is localized in both cytosolic and nuclear compartments, with enrichment in dendrites and synapses.
Role in Neurodegeneration
Alzheimer Disease
JNK1 plays a significant role in AD pathogenesis:
- Amyloid-β toxicity: JNK1 is rapidly activated by [Aβ](/proteins/amyloid-beta) oligomers and contributes to synaptic dysfunction
- [Tau](/proteins/tau) phosphorylation: JNK1 can phosphorylate [tau](/proteins/tau) at multiple sites (Thr181, Ser202, Thr231, Ser396)
- Neuroinflammation: JNK1 mediates cytokine-induced inflammatory responses in [astrocytes](/entities/astrocytes) and [microglia](/entities/microglia)
- Synaptic plasticity: JNK1 regulates AMPA receptor trafficking and [long-term potentiation](/mechanisms/long-term-potentiation) ([LTP](/mechanisms/long-term-potentiation))
- Neuronal apoptosis: JNK1 activation leads to mitochondrial apoptosis pathway
JNK1/2/3 deficiency protects against Aβ toxicity in mouse models, suggesting therapeutic potential.
Parkinson Disease
JNK1 contributes to PD through multiple mechanisms:
- Dopaminergic neuron death: JNK1 activation in substantia nigra pars compacta
- Mitochondrial dysfunction: JNK1 links mitochondrial stress to apoptosis
- [α-Synuclein](/proteins/alpha-synuclein) toxicity: JNK1 may phosphorylate α-syn and promote aggregation
- Neuroinflammation: JNK1 mediates microglial activation and cytokine release
Amyotrophic Lateral Sclerosis
- Motor neuron degeneration: JNK1/3 activation in SOD1 transgenic models
- Glial activation: JNK1 in astrocytes and [microglia](/cell-types/microglia-neuroinflammation) contributes to neuroinflammation
- Potential therapeutic target: JNK inhibitors show promise in preclinical models
Stroke and Ischemic Injury
- Ischemic stroke: JNK1 activation in penumbra contributes to secondary neuronal death
- Traumatic brain injury: JNK1 contributes to secondary damage mechanisms
- Neuroprotective strategies: JNK inhibitors (SP600125, SR 3306) in clinical trials
Huntington Disease
- Mutant [huntingtin](/proteins/huntingtin-protein) toxicity: JNK1 activation by mHTT
- Transcription dysregulation: JNK1 phosphorylates transcriptional regulators
- Therapeutic potential: JNK inhibitors in HD models
Therapeutic Implications
Challenges: JNK1 has both protective and pathogenic roles; complete inhibition may have adverse effects on immune function and development.
Research Directions
- Developing brain-penetrant selective JNK1 inhibitors
- Understanding isoform-specific (JNK1 vs JNK2 vs JNK3) functions
- Biomarkers for JNK1 activity in CNS
- Combination therapies with other pathway modulators (e.g., p38, PI3K/Akt)
See Also
- [MAPK8 Gene](/proteins/mapk8-protein)
- [MAPK9 Protein (JNK2)](/proteins/mapk9-protein)
- [MAPK10 Protein (JNK3)](/proteins/mapk10-protein)
- [JNK Signaling Pathway](/mechanisms/jnk-signaling-pathway)
- [Alzheimer Disease](/diseases/alzheimers-disease)
- [Parkinson Disease](/diseases/parkinsons-disease)
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
External Links
- [UniProt: MAPK8](https://www.uniprot.org/uniprot/P45985)
- [PDB: JNK1](https://www.rcsb.org/structure/1JNK)
- [Kegg: MAPK8](https://www.kegg.jp/kegg-bin/show_pathway?map=map04010)
Background
The study of Mapk8 Protein (Jnk1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[1]</sup> Davis RJ. (2000). Signal transduction by the JNK group of MAP kinases. Cell. PMID: 10648792(https://pubmed.ncbi.nlm.nih.gov/10648792/)
<sup>[2]</sup> Manning AM, Davis RJ. (2003). Targeting JNK for therapeutic benefit: From junkie to gem. Nat Rev Drug Discov. PMID: 12858587(https://pubmed.ncbi.nlm.nih.gov/12858587/)
<sup>[3]</sup> Pocivavsek A, et al. (2009). JNK activation in Alzheimer disease. J Neurosci Res. PMID: 19301434(https://pubmed.ncbi.nlm.nih.gov/19301434/)
<sup>[4]</sup> Ries V, et al. (2016). JNK signaling in Parkinson disease. Neurodegener Dis. PMID: 27055123(https://pubmed.ncbi.nlm.nih.gov/27055123/)
<sup>[5]</sup> Centeno C, et al. (2010). Role of JNK in ALS pathogenesis. Brain Res. PMID: 19815014(https://pubmed.ncbi.nlm.nih.gov/19815014/)